Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 17/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9606761 | 0.93 | PTGER4 (0.61) | PTGER4CYP1A2CYP2D6SMN1; SMN2PKM | |
| SCHEMBL14431077 | 0.92 | PTGER4 (0.48) | PTGER4CYP1A2CYP2D6 | |
| SCHEMBL12002087 | 0.91 | PTGER4 (0.43) | PTGER4CYP1A2CYP2D6SMN1; SMN2PKM | |
| SCHEMBL12002196 | 0.89 | PTGER4 (0.42) | PTGER4CYP1A2CYP2D6SMN1; SMN2PKM | |
| SCHEMBL10058526 | 0.88 | PTGER4 (0.56) | PTGER4CYP1A2CYP2D6PKM | |
| SCHEMBL9606836 | 0.88 | PTGER4 (0.53) | PTGER4CYP1A2CYP2D6SMN1; SMN2PKM | |
| SCHEMBL14430833 | 0.87 | PTGER4 (0.48) | PTGER4CYP1A2CYP2D6 | |
| SCHEMBL10058524 | 0.86 | PTGER4 (0.57) | PTGER4CYP1A2CYP2D6 | |
| SCHEMBL10058545 | 0.86 | PTGER4 (0.54) | PTGER4CYP1A2CYP2D6SMN1; SMN2PKM | |
| SCHEMBL14430836 | 0.86 | PTGER4 (0.43) | PTGER4CYP1A2CYP2D6SMN1; SMN2PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2457897-A1 | BENZO (F) ISOINDOL-2-YLPHENYL ACETIC ACID DERIVATIVES AS EP4 RECEPTOR AGONISTS | Glaxo Group Limited (GB) | 2012-05-30 | — | — | EP | disclosed |